Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that its French distributor has been awarded a new tender to supply hospitals in Paris with CardioQ-ODM+ equipment.
The Company’s French distribution partner, Gamida SA (“Gamida”), has won an eight year tender to supply CardioQ-ODM+ products to the Assistance Hopitaux Publique de Paris (‘AHPP’). AHPP is the public hospital system of the city of Paris and its suburbs. It includes over 40 hospitals and is linked to the University of Paris. The tender is for a total of not less than 34,000 disposable probes and has a minimum value of over €4m over the eight year tender.
The terms of the tender, which replaces a previous tender originally awarded in 2011 and extended in 2014, requires Gamida to supply 70 new CardioQ-ODM+ monitors free of charge to AHPP hospitals. Deltex is supporting this requirement by supplying the monitors at very low margin and has this month received orders of £0.1m for 50 monitor systems, with the remaining 20 monitors to be supplied out of Gamida’s own inventory.
Ewan Phillips, Deltex Medical Group PLC Chief Executive, commented: “This is the largest value tender ever awarded anywhere for the Company’s products and consolidates our strong market position in France, especially in Paris. France is our largest export market by volume and second only to the USA by value.”
